Vadim V Ptushkin

13PUBLICATIONS
89CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Respiratory diseasesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 19, 2026
Minimal residual disease-guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype.

|Feb 20, 2026
[Characteristics and 5-year outcomes in patients with chronic lymphocytic leukemia receiving ibrutinib (a real-world study)].

U P Ergasheva, E P Panchenko, C G Chernyshenko

|Sep 27, 2023
The Features of COVID-19's Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Vadim Ptushkin, Evgeniya Arshanskaya, Olga Vinogradova

|May 18, 2023
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.

Eugene Nikitin, Maria Kislova, Dmitry Morozov

|Jan 08, 2023
Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia.

Alexey A Komissarov, Maria Kislova, Ivan A Molodtsov

|Oct 26, 2022
[Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT)].

V V Ptushkin, M A Kunst, T A Mitina

Pageof 3

Frequent Collaborators

5 joint publications

Maria Kislova

5 joint publications

Eugene Nikitin

4 joint publications

Tatyana S Konstantinova

4 joint publications

Elena Dmitrieva